NASDAQ
Hillstream BioPharma, Inc. (HILS) has a free cash flow growth of 26.88% as of Friday, May 29, 2026. This represents a 125.52% increase compared to its 12-month average of -105.32%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.